Revolution Medicines and EQRx Stockholders Approve EQRx Acquisition
Benzinga
NOVEMBER 8, 2023
08, 2023 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. NASDAQ: RVMD ), a clinical-stage oncology company developing targeted therapies for RAS-addicted cancers, and EQRx, Inc. The final votes will be certified by an independent inspector of elections for each company and publicly reported following this certification.
Let's personalize your content